NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
31 hedge funds and large institutions have $3.98M invested in Nymox Pharmaceutical Corp in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
68% less call options, than puts
Call options by funds: $77K | Put options by funds: $244K
Holders
31
Holding in Top 10
–
Calls
$77K
Puts
$244K
Top Buyers
| 1 | +$657K | |
| 2 | +$117K | |
| 3 | +$88.6K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$88K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$77K |
Top Sellers
| 1 | -$744K | |
| 2 | -$189K | |
| 3 | -$66K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$46.6K |
| 5 |
Goldman Sachs
New York
|
-$36K |